These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1149303)

  • 41. Growth hormone response to propranolol and L--dopa in obese subjects.
    Barbarine A; De Marinis L; Troncone L
    Metabolism; 1978 Mar; 27(3):275-8. PubMed ID: 628352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cyproheptadine on the spontaneous diurnal variations of plasma ACTH-cortisol and ACTH-GH secretion induced by l-dopa.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1975 Dec; 23(10):406-9. PubMed ID: 177112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB; Shulman D; Root AW; Spiliotis BE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dopaminergic regulation of plasma growth hormone secretion in normal subjects.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Yoshinaga K
    Tohoku J Exp Med; 1986 Feb; 148(2):151-8. PubMed ID: 3961796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does short-term fasting desensitize human somatotrophs to oral L-dopa stimulation?
    Röjdmark S
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):721-8. PubMed ID: 3652472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of clonidine and standard provocative agents of growth hormone.
    Slover RH; Klingensmith GJ; Gotlin RW; Radcliffe J
    Am J Dis Child; 1984 Mar; 138(3):314-7. PubMed ID: 6322574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K; Inoue S; Shiraki J; Shishido T; Saito M; Numata K; Takamura Y
    Metabolism; 1991 Dec; 40(12):1257-62. PubMed ID: 1961117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification of the actions of some neuroactive drugs by growth hormone.
    Tang LC; Cotzias GC
    Arch Neurol; 1976 Feb; 33(2):131-4. PubMed ID: 1252146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
    Lee EJ; Kim KR; Lee KM; Lim SK; Lee HC; Lee JH; Lee DJ; Huh KB
    Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined oral L-dopa and propranolol for growth hormone provocation.
    Blackett PR; Altmiller DH; Seely JR; Cagas CR
    South Med J; 1979 Jul; 72(7):842-4. PubMed ID: 451694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
    Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
    Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of melatonin on L-tryptophan- and apomorphine-stimulated growth hormone secretion in man.
    Koulu M; Lammintausta R
    J Clin Endocrinol Metab; 1979 Jul; 49(1):70-2. PubMed ID: 447817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia.
    Szechtman H; Cleghorn JM; Brown GM; Kaplan RD; Franco S; Rosenthal K
    Psychiatry Res; 1988 Mar; 23(3):245-55. PubMed ID: 3387500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. L-dopa is a potent stimulator of cortisol in short children.
    Marakaki C; Papadimitriou DT; Papadopoulou A; Fretzayas A; Papadimitriou A
    Horm Res Paediatr; 2014; 81(6):386-90. PubMed ID: 24802138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.